--- title: "Stevanato Group S.p.A. (STVN) stock and investor profile" url: "https://aibio.space/companies/stevanato-s-p-a/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Stevanato Group S.p.A. (NYSE: STVN), United States. Listing facts, related biotech companies and news on aibio.space." --- STVN Stevanato Group S.p.A. NYSE · United States # Stevanato Group S.p.A. (STVN) news Stevanato Group S.p.A. is a public biotech or pharmaceutical company listed on NYSE under the ticker STVN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Stevanato Group S.p.A. news We have not published a story on Stevanato Group S.p.A. yet. When there is news, it will appear here. ## Stevanato Group S.p.A. at a glance - **Ticker**: STVN - **Listing**: NYSE - **Country**: United States - **Cash, Dec 31, 2025**: €141.4 million ### Related companies - [InMode](https://aibio.space/companies/inmode/) NASDAQ: INMD - [Functional Brands](https://aibio.space/companies/functional-brands/) OTC: MEHA - [Fresenius SE & Co. KGaA](https://aibio.space/companies/fresenius-fsnuy/) OTC: FSNUY - [MYOMO, INC.](https://aibio.space/companies/myomo/) NYSE: MYO - [National Vision Holdings](https://aibio.space/companies/national-vision/) NASDAQ: EYE - [PyroGenesis Canada](https://aibio.space/companies/pyrogenesis-canada/) OTC: PYRGF - [PANACEA LIFE SCIENCES HOLDINGS, INC.](https://aibio.space/companies/panacea-life-sciences/) OTC: PLSH - [FITLIFE BRANDS, INC.](https://aibio.space/companies/fitlife-brands/) NASDAQ: FTLF ### Also on NYSE - [Cadre Holdings](https://aibio.space/companies/cadre/) CDRE - [MYOMO, INC.](https://aibio.space/companies/myomo/) MYO - [WEST PHARMACEUTICAL SERVICES INC](https://aibio.space/companies/west-pharmaceutical-services/) WST - [ALCON INC](https://aibio.space/companies/alcon/) ALC - [Enovis CORP](https://aibio.space/companies/enovis/) ENOV - [3M CO](https://aibio.space/companies/3m/) MMM ## Stevanato Group S.p.A. annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [€1.19 billion](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | [€1.10 billion](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | | Research and development | [€25.4 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | [€31.7 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | | Net income (loss) | [€139.8 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | [€117.8 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | | Cash from operations | [€286.1 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | [€155.8 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | | Cash and equivalents | [€130.6 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | [€98.3 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | | Short-term investments | [€10.8 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | [€1.3 million](https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/) | Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents €130.6 million, plus short-term investments of €10.8 million, €141.4 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Stevanato Group S.p.A. What is the ticker symbol of Stevanato Group S.p.A.? Stevanato Group S.p.A. trades under the ticker STVN on NYSE. Where is Stevanato Group S.p.A. listed? Stevanato Group S.p.A. is listed on NYSE. Which country or territory is Stevanato Group S.p.A. listed under? Our directory records Stevanato Group S.p.A. under United States. Does aibio.space cover Stevanato Group S.p.A.? aibio.space lists Stevanato Group S.p.A. among 2,820 public biotech companies and publishes its news here as stories appear. ## Investor discussion: Stevanato Group S.p.A. Members talk about Stevanato Group S.p.A. (STVN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:STVN on TradingView](https://www.tradingview.com/symbols/NYSE-STVN/). ## Listing details Stevanato Group S.p.A. is a public biotech or pharmaceutical company listed on NYSE under the ticker STVN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Stevanato Group S.p.A. - **Ticker**: STVN - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/stevanato-s-p-a/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Stevanato Group S.p.A. (STVN) stock and investor profile", 2026-10-31, https://aibio.space/companies/stevanato-s-p-a/